Kaufman Development, led by real estate developer and investor Daniel Kaufman, announced today the launch of an expanded national development and investment platform focused on high-growth U.S.

New research reveals that switching from originator to biosimilar adalimumab for hidradenitis suppurativa may lead to reduced ...

Why are people spending more in these franchise categories, and what does that say about consumers today and opportunities ...

Discover a portfolio update with insights on Eli Lilly, MP Materials, and Meta. Learn why these investment moves could boost ...

These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the ...

Selling Dallas™, founded by nationally recognized real estate executive Darwin Stephens, CEO of RADDR Group™, announces his ...

Southbury resident Terry Murphy learned at a young age what it feels like to lose a loved one. She was just 10 years old when she found out her 16-year-old brother died unexpectedly. Decades later, ...

Some dogs might also show signs that would typically be associated with autism in humans. This could include an excessive ...

Siemens Healthineers AG ( OTCPK:SMMNY) Analyst/Investor Day November 17, 2025 8:00 AM EST ...

Philips has expanded its partnership with Cortechs.ai to integrate the company’s AI-driven neuroimaging analytics directly into Philips’ MR s ...

MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path ...

Vanda Pharmaceuticals stock rallies after phase II data show tradipitant sharply cuts Wegovy-related nausea and vomiting in overweight and obese adults.